Status:
COMPLETED
Observational Study of Lamotrigine
Lead Sponsor:
Northwell Health
Collaborating Sponsors:
GlaxoSmithKline
Conditions:
Epilepsy
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to assess efficacy, safety and tolerability of lamotrigine as used in a natural clinical setting, to examine the positive effects of lamotrigine, and the reasons why some ...
Detailed Description
There have been numerous randomized, double-blind controlled trials demonstrating the value of lamotrigine in the treatment of seizures. However, randomized trials take place in artificial experimenta...
Eligibility Criteria
Inclusion
- Patients who are about to be prescribed lamotrigine as an appropriate treatment for their epileptic disorder
Exclusion
- Patients with mental retardation
Key Trial Info
Start Date :
October 1 2001
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00299793
Start Date
October 1 2001
Last Update
March 23 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Long Island Jewish Medical Center
New Hyde Park, New York, United States, 11040